Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab vs BSC in chemorefractory KRAS wild-type mCRC
NCT01412957Phase 3Completed
- Sponsor
- Amgen
- Start
- Nov 2011
- Primary completion
- Jun 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 16
01
Overview
A Phase 3 trial of panitumumab in metastatic colorectal cancer (mCRC), sponsored by Amgen. Started Nov 2011; status: completed.
02
Drugs
panitumumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01412957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01412957.